Idera's stock has fallen by over 21% since Tuesday's announcement that BioCryst has pulled the merger between the two companies. Meanwhile, BioCryst stock jumped 8% before leveling off.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,